2020 Korean guidelines for the management of metastatic prostate cancer-Reference-Cited by-同舟云学术

2020 Korean guidelines for the management of metastatic prostate cancer

Published:2021-05-01 Issue:3 Volume:36 Page:491-514
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim In-Ho,Shin Sang Joon,Kang Byung Woog,Kang Jihoon,Kim Dalyong,Kim Miso,Kim Jin Young,Kim Chan Kyu,Kim Hee-Jun,Maeng Chi Hoon,Park Kwonoh,Park Inkeun,Bae Woo Kyun,Sohn Byeong Seok,Lee Min-Young,Lee Jae Lyun,Lee Junglim,Lim Seung Taek,Lim Joo Han,Chang Hyun,Jung Joo Young,Choi Yoon Ji,Kim Young Seok,Cho Jaeho,Joung Jae Young,Park Se Hoon,Lee Hyo Jin

Funder

Ministry of Health and Welfare

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2020-213.pdf

Reference132 articles.

1. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

2. Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline

3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study;Journal of Urologic Oncology;2024-03-31

2. Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer;Journal of Urologic Oncology;2023-11-30

3. Gender bias in shared decision‐making among cancer care guidelines: A systematic review;Health Expectations;2023-04-05

4. Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial;Asian Journal of Andrology;2023

5. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer;ESMO Open;2022-08